InvestorsHub Logo
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

Re: mc73 post# 2905

Wednesday, 10/28/2020 1:59:29 PM

Wednesday, October 28, 2020 1:59:29 PM

Post# of 3683
1. Many investors don’t understand what they hold here in ATHX is the next AMGN. ATHX now has 2 FDA designated RMAT therapies in Pivotal phase 3 trials and partner Healios is about to lock down data in matter of days and results will bring milestone payments and royalties upon approval in Japan.
2. USA is in a critical phase of the Covid 19 Pandemic, ATHX has the only FDA designated RMAT study MACOVIA for treatment of Covid induced ARDS. I am expecting FDA EUA in coming days for MULTISTEM.
3. Partnership talks are getting serious behind the scenes and ATHX is negotiating from position of strength as they have $80 Million in cash.
4. BARDA money is coming, BARDA needs an advanced therapy like MULTISTEM to stop the death toll.
5. ATHX will be $30.00+ same time next year .. GOOD LUCK LONGS